Stockscreener 앱 받기
0.3493
5.05%
0.0168
시간 외 거래:
.34
-0.0093
-2.66%
전일 마감가:
$0.3325
열려 있는:
$0.3202
하루 거래량:
3.54M
Relative Volume:
0.54
시가총액:
$14.51M
수익:
$62.71M
순이익/손실:
$-10.48M
주가수익비율:
-0.5544
EPS:
-0.63
순현금흐름:
$-13.77M
1주 성능:
+11.88%
1개월 성능:
-16.03%
6개월 성능:
+7.48%
1년 성능:
-84.54%
1일 변동 폭
$0.315
$0.3526
1주일 범위
$0.2774
$0.443
52주 변동 폭
$0.2179
$3.00
프로페이즈 Stock (PRPH) Company Profile
명칭
Prophase Labs Inc
전화
(215) 345-0919
주소
711 STEWART AVE, SUITE 200, NEW YORK, PA
PRPH을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
PRPH
Prophase Labs Inc
|
0.3493 | 13.81M | 62.71M | -10.48M | -13.77M | -0.63 |
|
TMO
Thermo Fisher Scientific Inc
|
489.01 | 183.16B | 43.21B | 6.58B | 6.17B | 17.29 |
|
DHR
Danaher Corp
|
210.93 | 150.53B | 24.01B | 3.41B | 4.86B | 4.70 |
|
IDXX
Idexx Laboratories Inc
|
650.84 | 52.32B | 4.04B | 985.66M | 774.34M | 12.01 |
|
A
Agilent Technologies Inc
|
119.20 | 33.77B | 6.63B | 1.17B | 1.19B | 4.05 |
|
IQV
Iqvia Holdings Inc
|
191.09 | 32.20B | 15.50B | 1.33B | 2.16B | 7.34 |
프로페이즈 Stock (PRPH) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2021-12-20 | 개시 | H.C. Wainwright | Buy |
| 2021-10-13 | 다운그레이드 | Dawson James | Buy → Neutral |
| 2021-01-20 | 개시 | Dawson James | Buy |
프로페이즈 주식(PRPH)의 최신 뉴스
ProPhase Labs Achieves Key U.S. Patent for Test - MSN
ProPhase Labs Inc (PRPH) Q2 2025 Earnings Call Highlights: Strategic Moves and Future Prospects - Yahoo Finance
Prophase Labs, Inc. shares fall 8.11% premarket as federal budget cuts and VC funding into oncology ventures. - AInvest
What is ProPhase Labs Inc. s revenue forecastJuly 2025 Intraday Action & Daily Market Momentum Tracking - sundaytimes.kr
Why did PRPH's Q4 2024 earnings surprise analysts? - AInvest
Volume Surge May Signal Institutional Interest in ProPhase Labs Inc.Trade Risk Assessment & Free AI Powered Buy and Sell Recommendations - sundaytimes.kr
Can ProPhase Labs Inc. deliver alphaCPI Data & Precise Swing Trade Alerts - thegnnews.com
ProPhase Labs announces full USPTO approval for issuance of U.S. patent - MSN
Price Channel Expanding on ProPhase Labs Inc.’s ChartTrade Ideas & Daily Entry Point Trade Alerts - beatles.ru
Prophase Labs shares rise 2.14% intraday after earnings results presentation. - AInvest
ProPhase Labs 2025 Q2 Earnings Improved Losses Despite Revenue Decline - AInvest
ProPhase Labs Reports Turnaround and Strategic Growth - TipRanks
ProPhase Labs Q2 2025 Earnings Call Transcript - MarketBeat
ProPhase Labs' Q2 2025: Unraveling Contradictions in Cancer Test Strategies and Crypto Investments - AInvest
ProPhase Labs, Inc. SEC 10-Q Report - TradingView
Transcript : ProPhase Labs, Inc., Q2 2025 Earnings Call, Aug 13, 2025 - MarketScreener
Earnings call transcript: ProPhase Labs Q2 2025 reveals EPS beat, stock drops - Investing.com Canada
ProPhase Labs Inc. To Present Second Quarter 2025 Financial Results On August 13, 2025 - Barchart.com
ProPhase Labs, Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2025 - MarketScreener
ProPhase Labs earnings beat by $0.04, revenue fell short of estimates - Investing.com Canada
ProPhase Labs Inc Reports Q2 2025 Earnings: EPS of $(0.11) Misses Estimate, Revenue Falls Short at $1.2 Million - GuruFocus
ProPhase Labs Posts Narrower Q2 Loss - The Motley Fool
ProPhase Labs Posts Narrower Q2 Loss - Nasdaq
ProPhase Labs Announces Financial Results for the Three and Six Months Ended June 30, 2025 | PRPH Stock News - GuruFocus
Can ProPhase Labs Inc. expand into new marketsJuly 2025 Macro Moves & Real-Time Volume Surge Alerts - newsyoung.net
ProPhase Labs Announces Financial Results for the Three and Six Months Ended June 30, 2025 - GlobeNewswire
ProPhase Labs Reports Q2 2025 Earnings, Secures Patent for BE-Smart Esophageal Adenocarcinoma Risk Assessment Test, and Advances Multiple Non-Dilutive Liquidity Initiatives. - AInvest
ProPhase Labs shares fall 1.13% premarket after receiving USPTO approval for biomarker-driven systems. - AInvest
ProPhase Labs Schedules Q2 2025 Earnings Release and Conference Call - AInvest
ProPhase Labs Earnings Preview: Analysts Expect $-0.15 EPS, Shares Down 85.7% Over the Last Year - AInvest
What caused PRPH's earnings to drop in Q3 2024? - AInvest
How did PRPH's 2024 earnings trend evolve? - AInvest
What does PRPH's earnings volatility indicate? - AInvest
ProPhase Labs Seeks Enhanced Shareholder Value through Reverse Merger and Bitcoin Integration - AInvest
ProPhase Labs (PRPH.O) Surges Over 33% — What’s Behind the Sharp Intraday Move? - AInvest
PRPH.O Surges 29.75%: Tracing the Source of the Sudden Intraday Spike - AInvest
ProPhase Labs Surges 23.75%: Patent Grant and Earnings Call Spark Volatility - AInvest
ProPhase Labs (PRPH) Surges 27.76% on Patent Approval and BE-Smart Validation—What’s Next for This Biotech Play? - AInvest
ProPhase Labs stock soars after securing patent for esophageal disease test By Investing.com - Investing.com South Africa
ProPhase Labs stock soars after securing patent for esophageal disease test - Investing.com
ProPhase Labs shares rise 35.82% premarket after receiving US patent for esophageal product. - AInvest
ProPhase Labs Gets US Patent For Esophageal Adenocarcinoma Risk Assessment; Shares Up Pre-Bell - MarketScreener
Why Is ProPhase Labs Stock (PRPH) Up 25% Today? - TipRanks
ProPhase Labs receives patent for Barrett’s esophagus testing technology By Investing.com - Investing.com South Africa
ProPhase Labs receives patent for Barrett’s esophagus testing technology - Investing.com
ProPhase Labs Announces Full USPTO Approval for Issuance of - GlobeNewswire
ProPhase Labs Secures Game-Changing Patent for Early Cancer Detection with 95% Accuracy Rate - Stock Titan
ProPhase Labs announces closing of $3M senior secured convertible notes - MSN
ProPhase Labs Inc. to Present Second Quarter 2025 Financial Results on August 13, 2025 - GlobeNewswire
ProPhase Labs to present Q2 2025 financial results on virtual conference call. - AInvest
ProPhase Labs Earnings: Biotech Leader Sets Q2 Financial Results Presentation This Week - Stock Titan
프로페이즈 (PRPH) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.67%
0.75%
자본화:
|
볼륨(24시간):